JVM CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30,300 KRW | +2.19% |
|
-1.94% | +14.34% |
| 12/03 | JVM Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | JVM Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
| Sales 2024 * | 176B 129M 10.78B | Sales 2025 * | 196B 144M 11.99B | Capitalization | 349B 256M 21.37B |
|---|---|---|---|---|---|
| Net income 2024 * | 30B 22.02M 1.84B | Net income 2025 * | 35B 25.69M 2.14B | EV / Sales 2024 * | 1.44 x |
| Net cash position 2024 * | 94.75B 69.55M 5.8B | Net cash position 2025 * | 125B 91.75M 7.65B | EV / Sales 2025 * | 1.14 x |
| P/E ratio 2024 * |
11.9
x | P/E ratio 2025 * |
10.3
x | Employees | 292 |
| Yield 2024 * |
1.49% | Yield 2025 * |
1.57% | Free-Float | 48.63% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.19% | ||
| 1 week | -1.94% | ||
| Current month | +1.34% | ||
| 1 month | -3.04% | ||
| 3 months | +2.54% | ||
| 6 months | +15.43% | ||
| Current year | +14.34% |
1 week
29 250.00
31 150.00
1 month
29 250.0032 800.00
Current year
25 100.0032 800.00
1 year
20 250.0039 850.00
3 years
12 800.0039 850.00
5 years
5 950.0039 850.00
10 years
5 950.0039 850.00
| Managers | Title | Age | Since |
|---|---|---|---|
Dong-Hwan Lee
CEO | Chief Executive Officer | 55 | 24/11/24 |
Sang-Wook Kim
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jong-Hoon Lim
BRD | Director/Board Member | 47 | - |
Gi-Seok Woo
BRD | Director/Board Member | 58 | - |
Hee-Jin Kim
BRD | Director/Board Member | 68 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/24/03 | 30,300 | +2.19% | 61,095 |
| 02/24/02 | 29,650 | -0.84% | 76,942 |
| 30/24/30 | 29,900 | -0.66% | 57,242 |
| 29/24/29 | 30,100 | -2.59% | 100,696 |
| 26/24/26 | 30,900 | 0.00% | 70,282 |
End-of-day quote Korea S.E., May 03, 2024
More quotes
JVM CO., LTD is a Korea-based company engaged in the manufacture of pharmacy automation systems. The Company mainly provides automatic tablet dispensing and packaging systems (ATDPSs), an automatic tablet classification and packing machine, which includes slide type, box type and drum type. In addition, the Company provides total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), automatic medication sorting and control systems (AccuPharm) and others. The Companyâs products are under the brand name of JVM. It distributes its products within domestic market and to overseas markets.
Calendar
09/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
30,300
KRW
Average target price
36,667
KRW
Spread / Average Target
+21.01%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +14.34% | 258M | |
| +7.84% | 218B | |
| +7.35% | 184B | |
| +13.04% | 135B | |
| +26.03% | 107B | |
| -1.33% | 62.38B | |
| +11.80% | 51.37B | |
| +4.81% | 50.9B | |
| +0.30% | 40.87B | |
| +2.78% | 36.28B |
- Stock Market
- Equities
- A054950 Stock
